Eric Richman - Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eric Richman since 7/7/2023

Holdings reported by Eric Richman for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 289,629 $1.12 M $3.86 Jul 1, 2024 Direct
Stock Option (right to buy) 15,000 $87.9 K $5.86 Jun 24, 2024 Direct Common Stock
Common Stock 14,829 $57.2 K $3.86 Jul 1, 2024 By Trust
Restricted Stock Units 0 $2.50 Sep 20, 2023 Direct Common Stock

Transactions reported by Eric Richman for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership